Dermatology Physician Assistant National Certifying Examination (PANCE) Practice

Question: 1 / 400

In which group of patients is Zostavax contraindicated?

Patients with a history of shingles

Zostavax, which is a live attenuated vaccine for the prevention of shingles (herpes zoster), is contraindicated in certain patient populations to ensure safety and effectiveness. The vaccine is specifically contraindicated in individuals with a current or historical diagnosis of shingles. This group already has active varicella zoster virus present, and administering the live vaccine could potentially exacerbate the existing condition or lead to vaccine-related complications.

While adults over 60 years of age are actually the primary target group for vaccination, and patients allergic to eggs or undergoing chemotherapy may require special considerations but are not outright contraindications for receiving Zostavax, patients with a history of shingles would not only not benefit from the vaccine but could also face health risks. Therefore, understanding the patient’s history with herpes zoster is crucial in determining the appropriateness of Zostavax vaccination.

Get further explanation with Examzify DeepDiveBeta

Adults over 60 years of age

Patients allergic to eggs

Chemotherapy patients

Next Question

Report this question

Download Dermatology Physician Assistant National Certifying Examination (PANCE) Practice PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy